Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes

BACKGROUND: Antiviral therapy for chronic hepatitis B (CHB) is effective and can substantially reduce the risk of progressive liver disease and hepatocellular carcinoma but is often administered for an indefinite duration. Adherence has been shown in clinical trials to maximize the benefit of therap...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Gastroenterol
Päätekijät: Allard, Nicole L., MacLachlan, Jennifer H., Dev, Anouk, Dwyer, James, Srivatsa, Geeta, Spelman, Timothy, Thompson, Alexander J., Cowie, Benjamin C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7203797/
https://ncbi.nlm.nih.gov/pubmed/32381025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01219-w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia